Philly CEAL- DECIDE+ Adaptation
Launched by UNIVERSITY OF PENNSYLVANIA · Dec 9, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The Philly CEAL-DECIDE+ Adaptation trial is studying how an enhanced program for community health workers (CHWs) can help people in Philadelphia manage their heart health better. This is especially important because heart disease affects many racial and ethnic minorities and underserved communities. The study will involve 500 residents aged 35 to 75 who have risk factors for heart disease, such as high blood pressure or diabetes, and who have unmet social needs like trouble with housing or food security. Participants will either take part in the DECIDE+ program, which includes group sessions and consultations with a CHW, or continue with standard CHW services.
To be eligible for the study, individuals must live in Philadelphia, be within the specified age range, have been told by a healthcare provider that they have a heart disease-related condition, and have at least one unmet social need. Participants can expect to attend nine group sessions and have regular consultations to help them improve their heart health and address any social challenges they face. This trial aims to find effective ways to support heart health while also considering the important social factors that can impact health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Reside in Philadelphia
- • Be between 35 and 75 years of age (inclusive)
- * Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- • 1. Pre-diabetes
- • 2. Diabetes
- • 3. Hypertension
- • 4. Hyperlipidemia/ high cholesterol)
- • 5. BMI \>=30.
- • Have completed an initial visit with a CEO CHW
- * Have one or more unmet social needs identified in the CEO Intake Form in the following areas:
- • 1. Housing Stability,
- • 2. Food security,
- • 3. Transportation to medical appointments and/or work, employment,
- • 4. Household utilities,
- • 5. Healthcare access,
- • 6. Health literacy, and
- • 7. Social support.
- • Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
- Exclusion Criteria:
- • Does not reside in Philadelphia
- • Not between 35 and 75 years of age (inclusive)
- * Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- • 1. Pre-diabetes
- • 2. Diabetes
- • 3. Hypertension
- • 4. Hyperlipidemia/ high cholesterol)
- • 5. BMI \>=30.
- • Has not completed an initial visit with a CEO CHW
- * Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas:
- • 1. Housing Stability,
- • 2. Food security,
- • 3. Transportation to medical appointments and/or work, employment,
- • 4. Household utilities,
- • 5. Healthcare access,
- • 6. Health literacy, and
- • 7. Social support.
- • Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Jose Bauermeister, MPH, PhD
Principal Investigator
University of Pennsylvania
Antonia Villarruel, RN, PhD
Principal Investigator
University of Pennsylvania
Carmen Alvarez, RN, PhD
Principal Investigator
University of Pennsylvania
Stephen Bonett, RN, PhD
Principal Investigator
University of Pennsylvania
Ashley Clemmons
Principal Investigator
Office of Community Empowerment and Opportunity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported